2016
Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012–2013
Su S, Fry AM, Kirley PD, Aragon D, Yousey‐Hindes K, Meek J, Openo K, Oni O, Sharangpani R, Morin C, Hollick G, Lung K, Laidler M, Lindegren ML, Schaffner W, Atkinson A, Chaves SS. Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012–2013. Influenza And Other Respiratory Viruses 2016, 10: 86-90. PMID: 26505742, PMCID: PMC4746564, DOI: 10.1111/irv.12355.Peer-Reviewed Original ResearchConceptsInfluenza Hospitalization Surveillance NetworkRespiratory virusesAvailable rapid influenza diagnostic testsRapid influenza diagnostic testsInfluenza diagnostic testsOptimal clinical managementInfection control practitionersSurvey of hospitalsDetection of influenzaSurveillance networkInfluenza infectionClinical managementCatchment populationStandardized questionnaireUS hospitalsHospitalDiagnostic testingInfluenzaLaboratory capacityTelephone interviewsDiagnostic testsMolecular diagnostic assaysInsensitive assayControl practitionersDiagnostic practice
2014
Lyme Disease Testing by Large Commercial Laboratories in the United States
Hinckley A, Connally N, Meek J, Johnson B, Kemperman M, Feldman K, White J, Mead P. Lyme Disease Testing by Large Commercial Laboratories in the United States. Clinical Infectious Diseases 2014, 59: 676-681. PMID: 24879782, PMCID: PMC4646413, DOI: 10.1093/cid/ciu397.Peer-Reviewed Original ResearchMeSH KeywordsBlotting, WesternEnzyme-Linked Immunosorbent AssayHumansImmunoenzyme TechniquesImmunologic TestsLaboratoriesLyme DiseaseSurveys and QuestionnairesUnited StatesConceptsNumber of infectionsLarge commercial laboratoriesSource patientsLyme diseaseLyme disease testingFrequency of infectionTotal direct costsTwo-tiered testingCommercial laboratoriesPositive testPatientsDisease testingDiagnostic recommendationsVolume of testingLD testingInfectionDirect costsExposure historyLD testLaboratory resultsLaboratory testingUnited StatesAlternative testingTotal number
2009
Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study
Connally NP, Durante AJ, Yousey-Hindes KM, Meek JI, Nelson RS, Heimer R. Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study. American Journal Of Preventive Medicine 2009, 37: 201-206. PMID: 19595558, DOI: 10.1016/j.amepre.2009.04.026.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAnimalsCase-Control StudiesChildChild, PreschoolConnecticutEnvironment DesignEnvironmental ExposureFemaleHumansHygieneInfantLogistic ModelsLyme DiseaseMaleMatched-Pair AnalysisMiddle AgedPopulation SurveillanceProspective StudiesResidence CharacteristicsRisk FactorsSurveys and QuestionnairesTicksYoung AdultConceptsCase-control studyLyme diseaseDisease prevention initiativesConditional logistic regressionDisease prevention measuresErythema migransPotential confoundersRecreational exposureLogistic regressionProspective ageDiseaseCase onsetPrevention resultsPrevention measuresPersonal protectionRiskHoursConfoundersMigransTicksInfectionStudyConnecticut communitiesMonths
2008
The mortality burden of chronic liver disease may be substantially underestimated in the United States.
Durante AJ, St Louis T, Meek JI, Navarro VJ, Sofair AN. The mortality burden of chronic liver disease may be substantially underestimated in the United States. Connecticut Medicine 2008, 72: 389-92. PMID: 18763665.Peer-Reviewed Original ResearchMeSH KeywordsCause of DeathChronic DiseaseDeath CertificatesHumansLiver DiseasesPopulation SurveillanceRetrospective StudiesSensitivity and SpecificitySurveys and QuestionnairesUnited StatesConceptsChronic liver diseaseICD-10 codesLiver diseaseEnd-stage liver diseaseStage liver diseaseDeath certificate dataCause of deathMedical examiner recordsCLD burdenCLD statusMedical chartsMortality burdenDeath certificatesCertificate dataHealth StatisticsCounty residentsDiseaseGold standardBurdenSerious diseaseDeathUnited States National CenterDetrimental effectsSpecificityPrevention